
Serving
Companies, Investors, and Patients
About Us
BrilLiquid was founded in 2013 with a mission to create liquidity for less liquid public and private companies and make capital markets more effective for issuers and investors.
How We Help
CAPITAL MARKETS ADVISORY
We deliver bespoke solutions to capital markets problems faced by public and private companies and their stakeholders:
- Investor targeting
- Capital raising
- Acquisitions
- Fundraising
- Liability management
BRILL.health
We operate BRILL.health, a patient-controlled health platform:
- Patient-summary curation (across providers, payers, pharmacies, and digital-health tools)
- Identity-verified records
- Secure messaging
- Consent-gated data sharing
APPLICATION DEVELOPMENT FOR REGULATED SECTORS
Develop innovative FinTech and HeathIT applications
- More than12 years of experience in AWS
- Operated SEC-approved Alternative Trading System (ATS)
- Experience with AML/KYC and Fincen, BSA
- HIPAA-compliant patient-centric applications
- Standards-based protocols
- Scalability while ensuring data sovereignty
CLIENT AND BUSINESS DEVELOPMENT
Develop strategic relationships and bespoke product marketing playbooks, product messaging across multiple channels and sales pitch decks:
- Strategic partnerships
- Product fact sheets
- Customer case studies
Select Publications
Consultations and Comment Letters
- Rule 10b5-1 and Insider Trading (SEC Proposal) Download
- Share Repurchase Disclosure Modernization (SEC Proposal) Download
- Updating EDGAR Filing Requirements (SEC Proposal) Download
- Reporting Threshold for Institutional Investment Managers (SEC Proposal) Download
- Our Paris Agreement Capital Transition Assessment (PACTA) of BlackRock's Form 13F Securities Download
Books
- "Sustainability and Capital Markets: Guide for US Companies" Preview on Amazon.com
- "Stock Buybacks: Equity Market Structure Considerations" Preview on Amazon.com
© 2026 BrilLiquid LLC
Capital Markets Advisory Services and Securities transactions are executed through Weild & Co., member FINRA | SIPC
Investors, please read Weild & Co.’s Regulation Best Interest Form CRS disclosure
Andrew MacInnes, founder of Brilliquid LLC, is registered with FINRA through Weild & Co.
Inquiries about specific securities, offerings, or investments should be directed to Weild & Co.
through their published channels and supervised by their compliance program.
BRILL.health is a Progressive Web App available globally
Tthe platform's policies, sub-processor disclosures, and security commitments are published at policies.brill.health
For inquiries about the BRILL.health platform, contact am@brilliquid.com
Inquiries, accounts, or interactions with the **BRILL.health** patient platform are not governed by this Policy.
They are governed by the BRILL.health Privacy Policy
which covers HIPAA-protected health information, sub-processor relationships, identity verification, consent grants, and the patient-curated record model.